Home

kocka Ösztönözni Előző oldal double expresor vs double hit overall survival Visszavonás Javítás élettartam

Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or  BCL6 rearrangements is not associated with MYC/IG gene rearrangements |  Haematologica
Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements | Haematologica

Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or  BCL6 rearrangements is not associated with MYC/IG gene rearrangements |  Haematologica
Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements | Haematologica

Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or  BCL6 rearrangements is not associated with MYC/IG gene rearrangements |  Haematologica
Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements | Haematologica

Increased MYC copy number is an independent prognostic factor in patients  with diffuse large B-cell lymphoma | Modern Pathology
Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma | Modern Pathology

Double-hit and double-protein-expression lymphomas: aggressive and  refractory lymphomas. | Semantic Scholar
Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas. | Semantic Scholar

How I treat double-hit lymphoma - ScienceDirect
How I treat double-hit lymphoma - ScienceDirect

Double Hit and Double Expresser Diffuse Large B Cell Lymphoma Subtypes:  Discrete Subtypes and Major Predictors of Overall Survival | Indian Journal  of Hematology and Blood Transfusion
Double Hit and Double Expresser Diffuse Large B Cell Lymphoma Subtypes: Discrete Subtypes and Major Predictors of Overall Survival | Indian Journal of Hematology and Blood Transfusion

Double-Hit' Lymphomas a Challenge for the Oncologist - The ASCO Post
Double-Hit' Lymphomas a Challenge for the Oncologist - The ASCO Post

Double Hit and Double Expresser Diffuse Large B Cell Lymphoma Subtypes:  Discrete Subtypes and Major Predictors of Overall Survival | Indian Journal  of Hematology and Blood Transfusion
Double Hit and Double Expresser Diffuse Large B Cell Lymphoma Subtypes: Discrete Subtypes and Major Predictors of Overall Survival | Indian Journal of Hematology and Blood Transfusion

Double-hit and double-protein-expression lymphomas: aggressive and  refractory lymphomas. | Semantic Scholar
Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas. | Semantic Scholar

Double hit lymphoma: How do we define it and how do we treat it? -  ScienceDirect
Double hit lymphoma: How do we define it and how do we treat it? - ScienceDirect

Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have  Inferior Progression-Free Survival After Autologous Stem-Cell  Transplantation. | Semantic Scholar
Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation. | Semantic Scholar

MYC protein expression scoring and its impact on the prognosis of  aggressive B-cell lymphoma patients | Haematologica
MYC protein expression scoring and its impact on the prognosis of aggressive B-cell lymphoma patients | Haematologica

Defining and treating high-grade B-cell lymphoma, NOS - ScienceDirect
Defining and treating high-grade B-cell lymphoma, NOS - ScienceDirect

Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit  and Double-Expressor Lymphoma - Biology of Blood and Marrow Transplantation
Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor Lymphoma - Biology of Blood and Marrow Transplantation

Double-hit and double-protein-expression lymphomas: aggressive and  refractory lymphomas - The Lancet Oncology
Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas - The Lancet Oncology

A) Number of cases of HGBCL (including double-hit lymphomas) and... |  Download Scientific Diagram
A) Number of cases of HGBCL (including double-hit lymphomas) and... | Download Scientific Diagram

Progression-free survival comparing double-hit lymphomas to... | Download  Scientific Diagram
Progression-free survival comparing double-hit lymphomas to... | Download Scientific Diagram

Outcomes of patients with double/triple expressor diffuse large B-cell  lymphoma (DLBCL) treated with R-DA-EPOCH/R-CHOP: A single-center  experience. - ScienceDirect
Outcomes of patients with double/triple expressor diffuse large B-cell lymphoma (DLBCL) treated with R-DA-EPOCH/R-CHOP: A single-center experience. - ScienceDirect

Progression-free survival (PFS) curves (A) and overall survival (OS)... |  Download Scientific Diagram
Progression-free survival (PFS) curves (A) and overall survival (OS)... | Download Scientific Diagram

Comparison of overall survival (OS). There is no statistically... |  Download Scientific Diagram
Comparison of overall survival (OS). There is no statistically... | Download Scientific Diagram

Overall survival comparison between patients with atypical double-hit... |  Download Scientific Diagram
Overall survival comparison between patients with atypical double-hit... | Download Scientific Diagram

Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have  Inferior Progression-Free Survival After Autologous Stem-Cell  Transplantation. | Semantic Scholar
Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation. | Semantic Scholar

Diffuse Large B Cell Lymphoma:
Diffuse Large B Cell Lymphoma:

Double-Expressor Lymphoma Is Associated with Poor Outcomes after Allogeneic  Hematopoietic Cell Transplantation - Biology of Blood and Marrow  Transplantation
Double-Expressor Lymphoma Is Associated with Poor Outcomes after Allogeneic Hematopoietic Cell Transplantation - Biology of Blood and Marrow Transplantation

Kaplan-Meier curves of progression-free survival and overall survival.... |  Download Scientific Diagram
Kaplan-Meier curves of progression-free survival and overall survival.... | Download Scientific Diagram

Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young  patients affected by double expressor diffuse large B-cell lymphoma |  Leukemia
Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma | Leukemia